Arrowhead Pharmaceuticals Inc.

(ARWR) Trade

By |

Profile

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Contact Information

Website: www.arrowheadpharma.com
Email: ir@arrowheadpharma.com
Main Phone: +1 626 304-3400
Address: 225 South Lake Avenue
Address 2: Suite 1050
State: CA
City / Town: Pasadena
Country: USA
Postal Code: 91101

Issuer Information

Exchange: NGS
CEO: Christopher Anzalone
Employees: 95
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

View More

Profile

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Contact Information

Website: www.arrowheadpharma.com
Email: ir@arrowheadpharma.com
Main Phone: +1 626 304-3400
Address: 225 South Lake Avenue
Address 2: Suite 1050
State: CA
City / Town: Pasadena
Country: USA
Postal Code: 91101

Issuer Information

Exchange: NGS
CEO: Christopher Anzalone
Employees: 95
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

View More
$ 48.35 $ -2.15 (-4.26%)
Last Price 48.35 Change $ -2.15 Change % -4.26 Tick N/A
Bid 47.00 Bid Size 200.00 Ask 143.70 Ask Size 100.00
Open 50.00 High 50.37 Low 46.93 Prev Close 50.50
Last Trade Volume 3.5 mi 52 Wk Hi 51.84 52 Wk Low 10.41
Market Cap 4.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 95,300,992.00 EPS (TTM) 0.46 PE Ratio 102.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 19
Number of Buys 1 10
Number of Sells 4 9
Net Activity -151000 560792
Last 10 Buys Shares
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Mauro Ferrari 1,000
Mauro Ferrari 1,000
Christopher Anzalone 1,000
Kenneth Myszkowski 1,000
Christopher Anzalone 1,000
Last 10 Sell Shares
Douglas B. Given 1,000
Kenneth Myszkowski 1,000
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Bruce D. Given 1,000
Bruce D. Given 1,000
Douglas B. Given 1,000
Kenneth Myszkowski 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 4.5 4.5 4.5 4.5
Mean Target Price Estimate 10.5 10.5 10.08 10.5
Standard Deviation 3.58 3.58 3.85 3.58
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 4 3
Moderate Buy 0 0 0 0
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1.33 1.67 1.8